191 related articles for article (PubMed ID: 11395385)
21. Characterization of ANIT-induced toxicity using precision-cut rat and dog liver slices cultured in a dynamic organ roller system.
Amin K; Ip C; Sato B; Le T; Green CE; Tyson CA; Behrsing HP
Toxicol Pathol; 2006; 34(6):776-84. PubMed ID: 17162535
[TBL] [Abstract][Full Text] [Related]
22. The effect of bile duct ligation, bile duct cannulation, and hypothermia on alpha-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis in rats.
Roberts RJ; Plaa GL
Gastroenterology; 1966 Jun; 50(6):768-74. PubMed ID: 5212377
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis and proliferation of intrahepatic bile duct after ischemia-reperfusion injury.
Xu WH; Ye QF; Xia SS
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):428-32. PubMed ID: 15313683
[TBL] [Abstract][Full Text] [Related]
24. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat.
Slott PA; Liu MH; Tavoloni N
Gastroenterology; 1990 Aug; 99(2):466-77. PubMed ID: 1694804
[TBL] [Abstract][Full Text] [Related]
25. The effect of prostanoids on hepatic bile flow in dogs with normal liver and bile duct cell hyperplasia.
Solomon H; Contis J; Li AP; Kaminski DL
Prostaglandins Leukot Essent Fatty Acids; 1996 Apr; 54(4):265-71. PubMed ID: 8804123
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation.
Alpini G; Glaser SS; Ueno Y; Pham L; Podila PV; Caligiuri A; LeSage G; LaRusso NF
Am J Physiol; 1998 Apr; 274(4):G767-75. PubMed ID: 9575860
[TBL] [Abstract][Full Text] [Related]
27. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
[TBL] [Abstract][Full Text] [Related]
28. A morphometric study of the epithelium lining the rat intrahepatic biliary tree.
Benedetti A; Bassotti C; Rapino K; Marucci L; Jezequel AM
J Hepatol; 1996 Mar; 24(3):335-42. PubMed ID: 8778202
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of intrahepatic bile duct component in normal adult human liver and in primary biliary cirrhosis.
Casali AM; Siringo S; Sofia S; Bolondi L; Di Febo G; Cavalli G
Pathol Res Pract; 1994 Feb; 190(2):201-6. PubMed ID: 8058574
[TBL] [Abstract][Full Text] [Related]
30. A microcholangiographic study of liver disease models in rats.
Lichtman SN; Wang J; Clark RL
Acad Radiol; 1995 Jun; 2(6):515-21. PubMed ID: 9419599
[TBL] [Abstract][Full Text] [Related]
31. Biliary excretion of taurocholate, organic anions and vinblastine in rats with alpha-naphthylisothiocyanate-induced cholestasis.
Kurihara H; Sano N; Takikawa H
J Gastroenterol Hepatol; 2005 Jul; 20(7):1069-74. PubMed ID: 15955216
[TBL] [Abstract][Full Text] [Related]
32. alpha-Naphthylisothiocyanate induced alterations in hepatic drug metabolizing enzymes and liver morphology: implications concerning anticarcinogenesis.
Leonard TB; Popp JA; Graichen ME; Dent JG
Carcinogenesis; 1981; 2(6):473-82. PubMed ID: 7273328
[TBL] [Abstract][Full Text] [Related]
33. Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administration.
Kossor DC; Meunier PC; Handler JA; Sozio RS; Goldstein RS
Toxicol Appl Pharmacol; 1993 Mar; 119(1):108-14. PubMed ID: 8470113
[TBL] [Abstract][Full Text] [Related]
34. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
[TBL] [Abstract][Full Text] [Related]
35. Acute Alpha-Naphthylisothiocyanate-induced Liver Toxicity in Germfree and Conventional Male Rats.
Cullen JM; Faiola B; Melich DH; Peterson RA; Jordan HL; Kimbrough CL; Miller RT
Toxicol Pathol; 2016 Oct; 44(7):987-97. PubMed ID: 27519817
[TBL] [Abstract][Full Text] [Related]
36. Cytokeratin expression in cells of the rodent bile duct developing under normal and pathological conditions.
Carthew P; Edwards RE; Hill RJ; Evans JG
Br J Exp Pathol; 1989 Dec; 70(6):717-25. PubMed ID: 2481489
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction.
Tracy TF; Tector AJ; Goerke ME; Kitchen S; Lagunoff D
Am J Pathol; 1993 Dec; 143(6):1574-8. PubMed ID: 8256850
[TBL] [Abstract][Full Text] [Related]
38. The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system.
Suzuki M; Takahashi T; Ouchi K; Matsuno S
Cancer; 1989 Aug; 64(3):658-66. PubMed ID: 2545324
[TBL] [Abstract][Full Text] [Related]
39. Variations of intrahepatic and proximal extrahepatic bile ducts.
Hribernik M; Gadzijev EM; Mlakar B; Ravnik D
Hepatogastroenterology; 2003; 50(50):342-8. PubMed ID: 12749217
[TBL] [Abstract][Full Text] [Related]
40. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice.
Türkçapar N; Bayar S; Koyuncu A; Ceyhan K
Hepatogastroenterology; 2003; 50(51):680-3. PubMed ID: 12828059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
